Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gelé

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapie|June 26, 2003
[Antilipemics: from prevention to protection]Régis Bordet, Patrick Gelé, Dominique Deplanque, et al.
Journal of Cardiovascular Electrophysiology|June 11, 2005
Ventricular arrhythmias following exposure of failing hearts to oxidative stress in vitroFrançois Brigadeau, Patrick Gelé, Christelle Marquié, et al.
Brain Research|January 2, 2007
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do notAlexandre Kreisler, Patrick Gelé, Jean-François Wiart, et al.
British Journal of Pharmacology|February 9, 2005
Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusionOlivier Pétrault, Thavarak Ouk, Sophie Gautier, et al.
Brain Research|October 21, 2004
Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidaseFrançois Puisieux, Dominique Deplanque, Hélène Bulckaen, et al.
Journal of Neurology|March 24, 2022
Long-term cognitive impairments following COVID-19: a possible impact of hypoxiaThibaut Dondaine, Florine Ruthmann, Fanny Vuotto, et al.
The European Journal of Neuroscience|November 5, 2004
Vigilance states in a parkinsonian model, the MPTP mouseChristelle Monaca, Charlotte Laloux, Jean-Marie Jacquesson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 8, 2003
Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic toleranceMichèle Bastide, Patrick Gelé, Olivier Pétrault, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunctionOlivier Pétrault, Michèle Bastide, Nicole Cotelle, et al.
Proteome Science|June 20, 2014
Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic strokePatrick Gelé, Valérie Vingtdeux, Camille Potey, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapie|June 26, 2003
[Antilipemics: from prevention to protection]Régis Bordet, Patrick Gelé, Dominique Deplanque, et al.
Journal of Cardiovascular Electrophysiology|June 11, 2005
Ventricular arrhythmias following exposure of failing hearts to oxidative stress in vitroFrançois Brigadeau, Patrick Gelé, Christelle Marquié, et al.
Brain Research|January 2, 2007
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do notAlexandre Kreisler, Patrick Gelé, Jean-François Wiart, et al.
British Journal of Pharmacology|February 9, 2005
Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusionOlivier Pétrault, Thavarak Ouk, Sophie Gautier, et al.
Brain Research|October 21, 2004
Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidaseFrançois Puisieux, Dominique Deplanque, Hélène Bulckaen, et al.
Journal of Neurology|March 24, 2022
Long-term cognitive impairments following COVID-19: a possible impact of hypoxiaThibaut Dondaine, Florine Ruthmann, Fanny Vuotto, et al.
The European Journal of Neuroscience|November 5, 2004
Vigilance states in a parkinsonian model, the MPTP mouseChristelle Monaca, Charlotte Laloux, Jean-Marie Jacquesson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 8, 2003
Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic toleranceMichèle Bastide, Patrick Gelé, Olivier Pétrault, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 27, 2004
The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunctionOlivier Pétrault, Michèle Bastide, Nicole Cotelle, et al.
Proteome Science|June 20, 2014
Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic strokePatrick Gelé, Valérie Vingtdeux, Camille Potey, et al.
Pageof 3